Skip to main content

Table 1 Clinical characteristics of patients at diagnosis

From: CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type

Characteristics

Presence

Presence %

Age at diagnosis (years) Median (range)

41 (17–89)

 

  ≤60

83

86.5

  >60

13

13.5

Gender

  

  Male

61

63.5

  Female

35

36.5

ECOG PS

  

  0, 1

88

91.7

  ≥2

8

8.3

Subtypes

  

  UNKTL

63

65.6

  EUNKTL

33

34.4

B-symptoms

48

50.0

Mass long diameter ≥5 cm

36

37.5

Local tumor invasion

61

63.5

Extranodal sites ≥2

57

59.4

Regional lymphadenopathy

51

53.1

Elevated serum LDH

41

42.7

Elevated serum β2 M*

40

67.8

Ann Arbor stage

  

  I, II

71

74.0

  III, IV

25

26.0

IPI score

  

  0, 1

58

60.4

  ≥2

38

39.6

KPI score

  

  0, 1

49

51.0

  ≥2

47

49.0

CD30 expression

  

  Positive

30

31.2

  Negative

66

68.8

Treatment

  

  Chemotherapy

35

36.5

  Chemotherapy + radiotherapy

61

63.5

  1. Abbreviations: ECOG PS Eastern Cooperative Oncology Group performance status, UNKTL upper aerodigestive tract NK/T-cell lymphoma, EUNKTL extra-upper aerodigestive tract NK/T-cell lymphoma, LDH lactate dehydrogenase, β 2 M Beta-2 microglobulin, IPI International Prognostic Index, KPI Korean Prognostic Index.
  2. *Serum β2 M was detected in 59 cases.